Summit Therapeutics Inc.SMMTNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank64
3Y CAGR-64.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-64.9%/yr
vs +216.9%/yr prior
Acceleration
-281.9pp
Decelerating
Percentile
P64
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$108355.00-99.3%
2024$15.01M+632.0%
2023$2.05M-18.5%
2022$2.51M-
2021$0.00-
2020$0.00-100.0%
2019$155399.00+523.6%
2018$24919.00-74.5%
2017$97667.00-
2016$0.00-